These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22226319)

  • 1. Induction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults.
    Fujimoto C; Takeda N; Matsunaga A; Sawada A; Tanaka T; Kimoto T; Shinahara W; Sawabuchi T; Yamaguchi M; Hayama M; Yanagawa H; Yano M; Kido H
    Influenza Other Respir Viruses; 2012 Nov; 6(6):396-403. PubMed ID: 22226319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults.
    Ainai A; Tamura S; Suzuki T; van Riet E; Ito R; Odagiri T; Tashiro M; Kurata T; Hasegawa H
    Hum Vaccin Immunother; 2013 Sep; 9(9):1962-70. PubMed ID: 23896606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys.
    Mizuno D; Kimoto T; Sakai S; Takahashi E; Kim H; Kido H
    Vaccine; 2016 Apr; 34(16):1881-8. PubMed ID: 26954466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.
    Renegar KB; Small PA; Boykins LG; Wright PF
    J Immunol; 2004 Aug; 173(3):1978-86. PubMed ID: 15265932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
    Ainai A; van Riet E; Ito R; Ikeda K; Senchi K; Suzuki T; Tamura SI; Asanuma H; Odagiri T; Tashiro M; Kurata T; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
    Microbiol Immunol; 2020 Apr; 64(4):313-325. PubMed ID: 31957054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
    Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML
    J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.
    Simon JK; Ramirez K; Cuberos L; Campbell JD; Viret JF; Muñoz A; Lagos R; Levine MM; Pasetti MF
    Clin Vaccine Immunol; 2011 Mar; 18(3):355-61. PubMed ID: 21228137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.
    Lambkin-Williams R; Gelder C; Broughton R; Mallett CP; Gilbert AS; Mann A; He D; Oxford JS; Burt D
    PLoS One; 2016; 11(12):e0163089. PubMed ID: 28005959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.
    Couch RB; Atmar RL; Franco LM; Quarles JM; Wells J; Arden N; Niño D; Belmont JW
    J Infect Dis; 2013 Mar; 207(6):974-81. PubMed ID: 23307936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs.
    Larsen DL; Karasin A; Zuckermann F; Olsen CW
    Vet Microbiol; 2000 May; 74(1-2):117-31. PubMed ID: 10799784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of immunoglobulins and antibodies to haemaglutinin and neuraminidase of influenza virus in nasal secretions after natural infection.
    Hrusková J; Syrůcek L; Tůmová B; Stumpa A; Brůcková M; Losová M; Berkovicová V
    Acta Virol; 1976 Apr; 20(2):126-34. PubMed ID: 5867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated influenza A vaccine (Alice) in an adult population: vaccine-related illness, serum and nasal antibody production, and intrafamily transmission.
    Minor TE; Dick EC; Dick CR; Inhorn SL
    J Clin Microbiol; 1975 Nov; 2(5):403-9. PubMed ID: 1104655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin-specific radioimmunoprecipitation assays for quantitation of nasal secretory antibodies to hemagglutinin of type A influenza viruses.
    Kasel JA; Six HR; Oborn CJ; Dreesman GR
    J Clin Microbiol; 1978 Aug; 8(2):171-6. PubMed ID: 100506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans.
    Morokutti A; Muster T; Ferko B
    Vaccine; 2014 Apr; 32(17):1897-900. PubMed ID: 24560674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine.
    Ainai A; Tamura S; Suzuki T; Ito R; Asanuma H; Tanimoto T; Gomi Y; Manabe S; Ishikawa T; Okuno Y; Odagiri T; Tashiro M; Sata T; Kurata T; Hasegawa H
    J Med Virol; 2012 Feb; 84(2):336-44. PubMed ID: 22170556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.
    Murphy BR; Phelan MA; Nelson DL; Yarchoan R; Tierney EL; Alling DW; Chanock RM
    J Clin Microbiol; 1981 Mar; 13(3):554-60. PubMed ID: 7240388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.